Trial Profile
Phase III study of Eltoprazine in adult patients with Attention-deficit hyperactivity disorder
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 15 Sep 2016
Price :
$35
*
At a glance
- Drugs Eltoprazine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- 15 Sep 2016 New trial record